Works matching IS 1120-009X AND VI 36 AND IP 5 AND DT 2024

Results: 8

The relationship between statin administration timing and survival outcomes in patients with cancer receiving immune checkpoint blockade.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2024, v. 36, n. 5, p. 435, doi. 10.1080/1120009X.2023.2290348

By:

Wang, Zihan;
See, Xin Ya;
Chiang, Cho-Hung;
Chang, Yu-Cheng;
Hsia, Yuan Ping;
Chiang, Cho-Hsien;
Peng, Cheng-Ming;
Chiang, Cho-Han

Publication type:

Article

Fixed-dose antiretroviral combinations in children living with human immunodeficiency virus type 1 (HIV-1): a systematic review.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2024, v. 36, n. 5, p. 355, doi. 10.1080/1120009X.2023.2297095

By:

Attaianese, Federica;
Dalpiaz, Irene;
Failla, Martina;
Pasquali, Elisa;
Galli, Luisa;
Chiappini, Elena

Publication type:

Article

Amikacin treatment in urinary tract infection patients: evaluating the risk of acute kidney injury – a retrospective cohort study.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2024, v. 36, n. 5, p. 398, doi. 10.1080/1120009X.2024.2319454

By:

Dagan, Avner;
Epstein, Danny;
Neuberger, Ami;
Isenberg, Jonathan

Publication type:

Article

In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2024, v. 36, n. 5, p. 389, doi. 10.1080/1120009X.2024.2313908

By:

Blondeau, Joseph M.;
Blondeau, Leah D.;
Fitch, Shantelle D.

Publication type:

Article

PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer in vitro and in vivo.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2024, v. 36, n. 5, p. 422, doi. 10.1080/1120009X.2023.2288742

By:

Deng, Lili;
Zhao, Yan;
Liu, Wen

Publication type:

Article

Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2024, v. 36, n. 5, p. 411, doi. 10.1080/1120009X.2023.2281759

By:

Wang, Xiaolan;
Liu, Caixia;
Wang, Jian;
Tian, Zexiang

Publication type:

Article

Does discontinuing bleomycin due to toxicity increase the risk of lymphoma progression? Real-life data from a homogeneous population of advanced stage Hodgkin lymphoma.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2024, v. 36, n. 5, p. 403, doi. 10.1080/1120009X.2023.2281089

By:

Yılmaz, Umut;
Zulfaliyeva, Güldane;
Güzelli, Adnan Nuri;
Özmen, Deniz;
Elverdi, Tuğrul;
Salihoğlu, Ayşe;
Eskazan, Ahmet Emre;
Öngören, Şeniz;
Başlar, Zafer;
Ar, Muhlis Cem

Publication type:

Article

Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review.

Published in:

Journal of Chemotherapy (Taylor & Francis Ltd), 2024, v. 36, n. 5, p. 370, doi. 10.1080/1120009X.2023.2278014

By:

Dou, He;
Yu, Ping yang;
Liu, Yu qi;
Zhu, Yue;
Li, Fu cheng;
Wang, You yu;
Chen, Xing yan;
Xiao, Min

Publication type:

Article